| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
Reprint requests to: Adrian R. Krainer, Cold Spring Harbor Laboratory, PO Box 100, Cold Spring Harbor, NY 11724, USA; e-mail: krainer{at}cshl.edu; fax: (516) 367-8453.
We previously showed that the authentic 5' splice site (5'ss) of the first exon in the human ß-globin gene is intrinsically stronger than a cryptic 5'ss located 16 nucleotides upstream. Here we examined by mutational analysis the contribution of individual 5'ss nucleotides to discrimination between these two 5'ss. Based on the in vitro splicing efficiencies of a panel of 26 wild-type and mutant substrates in two separate 5'ss competition assays, we established a hierarchy of 5'ss and grouped them into three functional subclasses: strong, intermediate, and weak. Competition between two 5'ss from different subclasses always resulted in selection of the 5'ss that belongs to the stronger subclass. Moreover, each subclass has different characteristic features. Strong and intermediate 5'ss can be distinguished by their predicted free energy of base-pairing to the U1 snRNA 5' terminus (
G). Whereas the extent of splicing via the strong 5'ss correlates well with the G, this is not the case for competition between intermediate 5'ss. Weak 5'ss were used only when the competing authentic 5'ss was inactivated by mutation. These results indicate that extensive complementarity to U1 snRNA exerts a dominant effect for 5'ss selection, but in the case of competing 5'ss with similarly modest complementarity to U1, the role of other 5'ss features is more prominent. This study reveals the importance of additional submotifs present in certain 5'ss sequences, whose characterization will be critical for understanding 5'ss selection in human genes.
Keywords: pre-mRNA splicing; 5' splice site; U1 snRNA; pseudouridine
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Ram, S. Schwartz, and G. Ast Multifactorial Interplay Controls the Splicing Profile of Alu-Derived Exons Mol. Cell. Biol., May 15, 2008; 28(10): 3513 - 3525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Abad, M. Vera, S. P. Jung, E. Oswald, I. Romero, V. Amin, P. Fortes, and S. I. Gunderson Requirements for gene silencing mediated by U1 snRNA binding to a target sequence Nucleic Acids Res., April 1, 2008; 36(7): 2338 - 2352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Roca, A. J. Olson, A. R. Rao, E. Enerly, V. N. Kristensen, A.-L. Borresen-Dale, B. S. Andresen, A. R. Krainer, and R. Sachidanandam Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics Genome Res., January 1, 2008; 18(1): 77 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kralovicova and I. Vorechovsky Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition Nucleic Acids Res., October 8, 2007; 35(19): 6399 - 6413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Akker, S. Misra, S. Aslam, E. L. Morgan, P. J. Smith, B. Khoo, and S. L. Chew Pre-Spliceosomal Binding of U1 Small Nuclear Ribonucleoprotein (RNP) and Heterogenous Nuclear RNP E1 Is Associated with Suppression of a Growth Hormone Receptor Pseudoexon Mol. Endocrinol., October 1, 2007; 21(10): 2529 - 2540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sahashi, A. Masuda, T. Matsuura, J. Shinmi, Z. Zhang, Y. Takeshima, M. Matsuo, G. Sobue, and K. Ohno In vitro and in silico analysis reveals an efficient algorithm to predict the splicing consequences of mutations at the 5' splice sites Nucleic Acids Res., September 25, 2007; 35(18): 5995 - 6003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Kierlin-Duncan and B. A. Sullenger Using 5'-PTMs to repair mutant beta-globin transcripts RNA, August 1, 2007; 13(8): 1317 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Buratti, M. Chivers, J. Kralovicova, M. Romano, M. Baralle, A. R. Krainer, and I. Vorechovsky Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization Nucleic Acids Res., July 26, 2007; 35(13): 4250 - 4263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Garg and P. Green Differing patterns of selection in alternative and constitutive splice sites Genome Res., July 1, 2007; 17(7): 1015 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xia, J. Bi, and Y. Li Identification of alternative 5'/3' splice sites based on the mechanism of splice site competition Nucleic Acids Res., December 4, 2006; 34(21): 6305 - 6313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sheth, X. Roca, M. L. Hastings, T. Roeder, A. R. Krainer, and R. Sachidanandam Comprehensive splice-site analysis using comparative genomics Nucleic Acids Res., September 1, 2006; 34(14): 3955 - 3967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Buratti, M. Baralle, and F. E. Baralle Defective splicing, disease and therapy: searching for master checkpoints in exon definition Nucleic Acids Res., July 19, 2006; 34(12): 3494 - 3510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Spena, M. L. Tenchini, and E. Buratti Cryptic splice site usage in exon 7 of the human fibrinogen B{beta}-chain gene is regulated by a naturally silent SF2/ASF binding site within this exon RNA, June 1, 2006; 12(6): 948 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Belancio, D. J. Hedges, and P. Deininger LINE-1 RNA splicing and influences on mammalian gene expression Nucleic Acids Res., March 22, 2006; 34(5): 1512 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Konarska and C. C. Query Insights into the mechanisms of splicing: more lessons from the ribosome Genes & Dev., October 1, 2005; 19(19): 2255 - 2260. [Full Text] [PDF]
|
|
|
|
|
|
M. Freund, M. J. Hicks, C. Konermann, M. Otte, K. J. Hertel, and H. Schaal Extended base pair complementarity between U1 snRNA and the 5' splice site does not inhibit splicing in higher eukaryotes, but rather increases 5' splice site recognition Nucleic Acids Res., September 9, 2005; 33(16): 5112 - 5119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lei, I. N. M. Day, and I. Vorechovsky Exonization of AluYa5 in the human ACE gene requires mutations in both 3' and 5' splice sites and is facilitated by a conserved splicing enhancer Nucleic Acids Res., July 14, 2005; 33(12): 3897 - 3906. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
